Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v17-FR Version v10-EN
Language French English
Date Updated 2017-06-13 2017-05-24
Drug Identification Number 02244394 02244394
Brand name APO-CEFUROXIME APO-CEFUROXIME
Common or Proper name CEFUROXIME CEFUROXIME
Company Name APOTEX INC APOTEX INC
Ingredients CEFUROXIME CEFUROXIME
Strength(s) 500MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code J01DC J01DC
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-03-31 2017-03-31
Actual start date 2017-03-27 2017-03-27
Estimated end date 2017-06-15 2017-06-07
Actual end date 2017-06-09
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments